Apeiron Capital LTD Staar Surgical CO Transaction History

Apeiron Capital LTD

$115 Million
Q2 2024

A detailed history of Apeiron Capital LTD transactions in Staar Surgical CO stock. As of the latest transaction made, Apeiron Capital LTD holds 247,120 shares of STAA stock, worth $7.51 Million. This represents 10.19% of its overall portfolio holdings.

Number of Shares

247,120

Previous 351,312 29.66%

Holding current value

$7.51 Million

Previous $13.4 Million 12.51%

% of portfolio

10.19%

Previous 7.35%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$38.07 - $52.25 $3.97 Million - $5.44 Million	-104,192 Reduced 29.66%	247,120 $11.8 Million
Q1 2024 Apr 11, 2024	SELL	$27.67 - $39.61 $11,068 - $15,844	-400 Reduced 0.11%	351,312 $13.4 Million
Q3 2023 Oct 31, 2023	SELL	$39.39 - $58.12 $1.71 Million - $2.52 Million	-43,441 Reduced 10.99%	351,712 $14.1 Million
Q2 2023 Jul 24, 2023	SELL	$50.45 - $72.82 $6.45 Million - $9.31 Million	-127,872 Reduced 24.45%	395,153 $20.8 Million
Q1 2023 Apr 24, 2023	BUY	$51.25 - $79.34 $9.5 Million - $14.7 Million	185,386 Added 54.91%	523,025 $33.4 Million
Q4 2022 Jan 17, 2023	SELL	$46.82 - $76.2 $3.25 Million - $5.29 Million	-69,461 Reduced 17.06%	337,639 $0
Q4 2021 Jan 26, 2022	BUY	$88.02 - $127.79 $1.24 Million - $1.8 Million	14,100 Added 3.59%	407,100 $37.2 Million
Q3 2021 Oct 29, 2021	BUY	$122.75 - $162.68 $3.19 Million - $4.23 Million	26,000 Added 7.08%	393,000 $50.5 Million
Q1 2021 Apr 12, 2021	BUY	$78.5 - $126.48 $4.08 Million - $6.58 Million	52,000 Added 16.51%	367,000 $38.7 Million
Q4 2020 Jan 29, 2021	BUY	$55.93 - $82.78 $17.6 Million - $26.1 Million	315,000 New	315,000 $25 Million

Others Institutions Holding STAA

# of Institutions

242

Shares Held

46.9M

Call Options Held

230K

Put Options Held

154K

View Full List

About STAAR SURGICAL CO

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.46B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

More about STAA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Capital LTD with notifications on news.

Account

Apeiron Capital LTD Staar Surgical CO Transaction History